Bilateral intraocular inflammation after intravitreal bevacizumab in Behcet's disease

7 638

Cited 8 times in

MeSH: Adult ; Angiogenesis Inhibitors/adverse effects* ; Anterior Chamber ; Anti-Inflammatory Agents/therapeutic use ; Antibodies, Monoclonal/adverse effects* ; Antibodies, Monoclonal, Humanized ; Behcet Syndrome/drug therapy* ; Bevacizumab ; Eye Diseases/chemically induced* ; Eye Diseases/drug therapy ; Humans ; Immunosuppressive Agents/therapeutic use ; Inflammation/chemically induced ; Inflammation/drug therapy ; Intravitreal Injections ; Male ; Treatment Outcome ; Visual Acuity

Appears in Collections:: 1. College of Medicine (의과대학) > Dept. of Ophthalmology (안과학교실) > 1. Journal Papers

Yonsei Authors: Bae, Jeong Hun(배정훈)
Lee, Sung Chul(이성철) https://orcid.org/0000-0001-9438-2385

Show full item record Find it @ YMLIB

YUHSpace: Bilateral intraocular inflammation after intravitreal bevacizumab in Behcet's disease